Thrombolytic therapy for cardiac arrest due to pulmonary embolism after varicose vein surgery

Intern Med. 2012;51(14):1899-902. doi: 10.2169/internalmedicine.51.7149. Epub 2012 Jul 15.

Abstract

Anticoagulant therapy is the mainstay in the management of venous thromboembolism. Nevertheless, the situation is entirely different in the patients with submassive or massive pulmonary embolism (PE) and cardiac arrest, and the diagnosis and therapy strategy for such conditions are lacking. This patient, who presented with a cardiac arrest event after varicose vein surgery, was diagnosed as acute pulmonary embolism. She survived after administration of 50 mg recombinant tissue plasminogen activator (rt-PA) for over half an hour, along with continued anticoagulant therapy. Unfortunately, gastrointestinal and cerebral hemorrhaging occurred during the process.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Female
  • Fibrinolytic Agents / administration & dosage
  • Fibrinolytic Agents / adverse effects
  • Heart Arrest / drug therapy*
  • Heart Arrest / etiology*
  • Humans
  • Intracranial Hemorrhages / etiology
  • Postoperative Complications / drug therapy
  • Postoperative Complications / etiology
  • Pulmonary Embolism / complications*
  • Pulmonary Embolism / drug therapy*
  • Thrombolytic Therapy* / adverse effects
  • Tissue Plasminogen Activator / administration & dosage
  • Tissue Plasminogen Activator / adverse effects
  • Varicose Veins / surgery*

Substances

  • Fibrinolytic Agents
  • Tissue Plasminogen Activator